Gyros previews next generation of Gyrolab Workstation for protein quantification at nanoliter scale

Gyros previews next generation of Gyrolab Workstation for protein quantification at nanoliter scale Gyros has decided to preview Gyrolab Workstation, with its new laser- induced fluorescence detector for protein quantification, at the American Society of Mass Spectrometry meeting in Montreal, Canada, June 8-12. Those who attend will have a possibility to obtain more information. The concept was presented at a recent meeting of the American Association of Immunologists. "Scientists can now run established sandwich-based immunoassays at nanoliter scale in a CD microlaboratory." explained Per Sjöberg, Executive Vice-President Marketing and Sales at Gyros AB, "Gyrolab Bioaffy and our sample preparation CD, Gyrolab MALDI, are both run on Gyrolab Workstation, demonstrating the flexibility of Gyros technology platform. Users can benefit from a single instrument that runs different application CDs as required." Mr. Sjöberg continued, "Our development strategy is to focus on areas in which miniaturization and integration of protein applications into a CD microlaboratory have clear advantages. Gyrolab Bioaffy will allow the customer to assay their proteins in a format optimized for working with small volumes and many samples. Working at nanoliter scale will give a major reduction in sample and reagent consumption per data point. Many time-consuming and costly investigations caused by limited availability of sample, such as biomarker profiling in small animal models, can be reduced to days rather than weeks since more proteins can be assayed in a single sample." Mr. Sjöberg added. "Demonstrations and customer collaborations can be performed at our facilities in Princeton, New Jersey and in Uppsala, Sweden. Anyone with a serious interest is welcome to contact their Gyros representative to arrange a visit." About Gyros AB Gyros miniaturizes and integrates laboratory applications, enabling scientists to generate more information from less sample and to improve lab performance. Using our proprietary technology platform, we increase productivity by streamlining the many steps of conventional applications into single, nanoliter scale procedures. Optimal environments are created for each application. A Gyrolab microlaboratory, in the form of a compact disk, can process hundreds of samples in parallel, under the control of Gyrolab Workstation. Our company will realize the full potential of the Gyros technology platform in the fields of drug discovery and diagnostics. Initial product offerings are focused towards the growing area of proteomics. Gyros has more than 90 employees working at its headquarters in Uppsala Science Park, Sweden and in sales offices in the USA and Europe. For further information, visit www.gyros.com or contact: Maris Hartmanis, President and CEO, Gyros AB Tel: +46 (0)18 566 330 Mobile: +46 (0)70 562 8617 Email: maris.hartmanis@gyros.com Per Sjöberg, Executive Vice President Commercial Operations, Gyros AB Tel: +46 (0)18 566 318 Mobile: +46 (0)70 544 4799 Email: per.sjoberg@gyros.com Sue Cresswell, Marketing Communications Tel: +46 (0)8 54472620 Mobile: +46 (0)70 551 9520 Email: sue.cresswell@gyros.com Statements in this press release that are not strictly historical may be forward-looking and include risks and uncertainties. Therefore, though based on Gyros' current expectations, it should be duly noted that a variety of factors could cause actual results and experiences to differ materially from what is herein expressed. Risks and uncertainties include, but are not limited to, risks associated with the management of growth and international operations (including effects of currency fluctuations), variability of operating results, unforeseen changes in the diagnostic and pharmaceutical markets, market competition, rapid or unexpected changes in technologies, fluctuations in product demand, difficulties to successfully develop, adapt, produce or commercialize products, the ability to identify and develop new products and to differentiate products from those of competitors, as well as various legal hazards. Gyros, Gyrolab and the Gyros logo are registered trademarks of Gyros AB. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/06/04/20030603BIT00200/wkr0001.doc http://www.waymaker.net/bitonline/2003/06/04/20030603BIT00200/wkr0002.pdf

About Us

Gyros miniaturizes and integrates laboratory processes into application-specific Gyrolab? microlaboratories that process hundreds of samples in parallel at nanoliter scale. Scientists generate more information from less sample, improve lab performance and increase productivity.